PAH device
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT04555161
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Phase: N/A
Role: Lead Sponsor
Start: Mar 15, 2021
Completion: Oct 31, 2026
NCT05001711
Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension
Start: Jul 12, 2021
Completion: Jan 6, 2022
Loading map...